(Q40055816)

16 September 2017

Metabolic syndrome increases the risk of aggressive prostate cancer detection (English)

1 reference

16 September 2017

1 reference

1 reference

9

1 reference

16 September 2017

Juan Morote

1

1 reference

16 September 2017

Jordi Ropero

2

1 reference

16 September 2017

Jacques Planas

3

1 reference

16 September 2017

Juan M Bastarós

4

1 reference

16 September 2017

Gueisy Delgado

5

1 reference

16 September 2017

José Placer

6

1 reference

16 September 2017

Anna Celma

7

1 reference

16 September 2017

Inés M de Torres

8

1 reference

16 September 2017

Jaume Reventós

10

1 reference

16 September 2017

Andreas Doll

11

1 reference

16 September 2017

9 August 2012

1 reference

16 September 2017

1 reference

16 September 2017

111

1 reference

16 September 2017

7

1 reference

16 September 2017

1031-1036

1 reference

16 September 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

Metabolic alterations and targeted therapies in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

HYPOGONADISM AND METABOLIC SYNDROME: IMPLICATIONS FOR TESTOSTERONE THERAPY

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

Racial differences in risk of prostate cancer associated with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

The metabolic syndrome is associated with reduced risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

Physical activity or fitness and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

Contribution of age and declining androgen levels to features of the metabolic syndrome in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

Androgen deficiency, diabetes, and the metabolic syndrome in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

The metabolic syndrome and risk of prostate cancer in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

Is statin use associated with prostate cancer aggressiveness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

Features of the metabolic syndrome and prostate cancer in African-American men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11406.X

10.1111/J.1464-410X.2012.11406.X

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference